logo-loader
NASDAQ:NTRP

Neurotrope

Receive alerts
Market:
NASDAQ
Market Cap:
$73.18 m
Price
$5.62
Change
-3.60%
52 weeks high
9.50
52 weeks low
3.34

Viewing results 1-6 of 6

Health

Neurotrope and Anavex are 'making progress' with Alzheimer's programs, says Maxim Group

Experts are optimistic biotechs may be turning the corner on the mind-robbing disease after years of failure...

on 07/27/2018
Health

Neurotrope welcomes industry veteran to board

Neurotrope, which is developing a disruptive therapy for the treatment of severe Alzheimer’s disease, has appointed an industry veteran to the board. ...

on 02/19/2016
Health

Thursday's followed - global share sell off and contrary Tesla

The turmoil in global equities and the oil price slide continues....and in other news......

on 02/11/2016
Health

Neurotrope candidate in bid to treat Alzheimer's

Neurotrope revealed first patients have been dosed in its phase 2b clinical trial of lead candidate Bryostatin-1 for advanced Alzheimer’s disease....

on 02/11/2016
Health

Neurotrope raising US$15.3mln to fund Alzheimer’s drug trial

It could be the first step in raising a total of around US$150mln and it will support a Phase 2b clinical trial...

on 11/16/2015